Live feed
Filing
SC 13D/A
SC 13D/A0000950103-16-018451·CASI Pharmaceuticals, Inc (DE)
Schedule 13D ownership disclosure
CASI PHARMACEUTICALS INC
Security class unavailable · CUSIP: 14757U109
Event date: 2016-07-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 16.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950103-16-018451
- Form type
- SC 13D/A
- Filer
- CASI Pharmaceuticals, Inc (DE)
- CIK
- CIK 895051
- Filed
- Dec 05, 2016
- Reporting period
- Jul 27, 2016
- Description
- Schedule 13D beneficial ownership